18955-75-4Relevant articles and documents
Unexpected trifluoromethylated pyrazoles from ethyl 2-diazo-4,4,4-trifluoroacetoacetate and 1-diethylamino-prop-1-yne
Guillaume, Michel,Janousek, Zdenek,Viehe, Heinz G.,Wynants, Chantal,Declercq, Jean-Paul,Tinant, Bernard
, p. 253 - 256 (1994)
Ethyl 2-diazo-4,4,4-trifluoroacetoacetate reacts with N,N-diethylamino-prop-1-yne via an unusual pathway: the ynamine first reacts with the carbonyl adjacent to CF3, leading to a non-isolated vinyldiazomethane, which undergoes intramolecular cyclisation and then a -shift to afford a pyrazole. - Keywords: Trifluoromethylated pyrazoles; Intramolecular cyclisation; Ynamine reaction; NMR spectroscopy; IR spectroscopy
Synthesis of 3-acyl-5,6-dihydro-1,4-oxathiines through ring expansion of thiiranes
Chen, Xingpeng,Xu, Jiaxi
supporting information, p. 1651 - 1654 (2017/04/04)
Synthesis of 3-acyl-5,6-dihydro-1,4-oxathiines has been achieved via reactions of thiiranes and α-diazo-β-1,3-dicarbonyl compounds under microwave and copper sulfate-assisted conditions. The current method provides a direct and simple strategy in efficient preparation of 3-acyl-1,4-oxathiines from readily available thiiranes and trans-3-acyl-5,6-dihydro-1,4-oxathiines as stereospecific products for 1,2-disubstituted cis-thiiranes. The reaction mechanism was also proposed.
OXAZOLE OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 68, (2015/02/25)
The present invention is directed to oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the oxazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.